CatalystPit

ANTXAN2 Therapeutics, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $5.32 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$200.76M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-16 · Trenor Cameron C. III (Chief Medical Officer) · OTHER
  • 2026-09-11 · Readnour Robin Shane (Director) · SELL
  • 2026-09-08 · Readnour Robin Shane (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders69
Shares held26,228,708
Value$121.06M
Percent of shares outstanding69.51%
As of quarter end2026-06-30
RECENT NEWS
  • Purcell & Lefkowitz investigates AN2 Therapeutics on shareholder behalf
  • AN2 Therapeutics: A Failed Drug Could Become A Major Value Driver
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS